Article
Gene therapy for cancer: regulatory considerations for approval
20 Nov 2015
Abstract excerpt
The rapidly changing field of gene therapy promises a number of innovative treatments for cancer patients. Advances in genetic modification of cancer and immune cells and the use of oncolytic viruses and bacteria have led to numerous clinical trials for cancer therapy, with several progressing to late-stage product development. At the time of this writing, no gene therapy product has been approved by the United...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
